Find Academic Supervisors

Maria CraigView profile

Professor

• Childhood Diabetes
• Type 1 Diabetes
• Virology and Diabetes
• +4 more

Professor Maria Craig is a distinguished academic and researcher at the University of New South Wales, Faculty of Medicine & Health, specializing in childhood diabetes research. She holds a prominent position as a Professor with extensive contributions to the field of pediatric endocrinology and diabetes, particularly focusing on type 1 diabetes in children. Professor Craig's educational background includes: MB BS from the University of Melbourne MMedSc(ClinEpid) from the University of Newcastle PhD from the University of Sydney FRACP (Fellow of the Royal Australasian College of Physicians) Professor Craig's research primarily focuses on childhood diabetes, with special emphasis on prediction and prevention of type 1 diabetes. She has a significant interest in the association between viruses and type 1 diabetes, collaborating with the Virology Research Group at Prince of Wales Hospital (POWH). Together with Professor Bill Rawlinson, she leads the viral theme for the multicentre ENDIA study (endia.org.au). As principal investigator for the CoRD trial, she is conducting a world-first phase 1 study using autologous cord blood for prevention of type 1 diabetes in children with islet autoimmunity. Additionally, she serves as principal investigator for the Australasian Diabetes Data Network (ADDN). Her research portfolio also encompasses the epidemiology of various forms of childhood diabetes (type 1, type 2, cystic fibrosis related diabetes and monogenic diabetes) and diabetes complications, in collaboration with Professor Kim Donaghue at the Children's Hospital at Westmead. Professor Craig's extensive publication record, including over 361 journal articles, demonstrates her leadership in advancing our understanding of childhood diabetes. Her recent work shows increasing focus on early detection methods, risk prediction models, technological interventions for diabetes management, and the complex interplay between viral infections and autoimmune diabetes development. She has been instrumental in developing clinical practice guidelines through her role as co-editor of the International Society for Pediatric and Adolescent Diabetes (ISPAD) guidelines. Professor Craig has received numerous prestigious awards recognizing her contributions to pediatric endocrinology and diabetes research: Australian Paediatric Endocrine Group Young Investigator's Award (1997) Asia Pacific Paediatric Endocrine Society Clinical Teaching Award (2008) Lifetime Honorary Member, Caring and Living as Neighbours (2013) Australian Diabetes Society Jeff Flack Diabetes Data Award (2019) Australian Paediatric Endocrine Group Norman Wettenhall Award for Research and Innovation (2019) Throughout her career, Professor Craig has demonstrated exceptional leadership in professional societies, having served as former president/treasurer of the Australasian Paediatric Endocrine Group (APEG) and currently as Scientific Convenor of the Asia Pacific Paediatric Endocrine Society Fellows school. Her work with the ENDIA study and Australasian Diabetes Data Network represents significant collaborative research efforts involving multiple institutions across Australia and internationally. Her principal investigator roles for major studies indicate substantial research funding support. Professor Craig leads several important research initiatives including the ENDIA study, the CoRD trial, and the Australasian Diabetes Data Network. These programs involve multidisciplinary teams of researchers, clinicians, and support staff working collaboratively to advance understanding and treatment of childhood diabetes. Her work at the intersection of virology and diabetes represents a unique and innovative approach to understanding the environmental triggers of type 1 diabetes.

Peninah MurageView profile

Assistant Professor

• Environmental Epidemiology
• Climate Change
• Health Geography
• +5 more

Dr Peninah Murage is an Assistant Professor at the London School of Hygiene & Tropical Medicine in the Department of Public Health, Environments and Society under the Faculty of Public Health and Policy. She specializes in environmental epidemiology with a PhD in Health Geography and focuses on health impacts of environmental changes, particularly climate change mitigation and adaptation strategies. Affiliation: Centre on Climate Change and Planetary Health Her research explores climate change effects on health outcomes like heat-related mortality, cardiovascular diseases, and cognitive development in children. She integrates GIS/spatial analysis with public health and policy frameworks to identify nature-based solutions for sustainable development. Current work examines systemic inequalities in heat risk exposure and interventions such as tree-based strategies in low-income settings. Key grants include: Health Protection Research Unit on Climate Change and Health Security (2025-2030, NIHR) Climate Change and Non-Communicable Diseases in Senegal (2024-2027) Pathfinder 2: Accelerating Climate Action for Health (2023-2026) She actively contributes to the Lancet Pathfinder Commission and serves on the Executive Committee of the International Society of Environmental Epidemiology (African Chapter).

• Iron Homeostasis
• Cell Physiology
• Systems Biology
• +4 more

Dr. Samira Lakhal-Littleton is an Associate Professor of Cell Physiology and MRC Senior Non-Clinical Research Fellow at the University of Oxford, affiliated with the Department of Physiology, Anatomy and Genetics and Brasenose College. Her research focuses on iron homeostasis, systems biology, and oxygen sensing mechanisms in cardiovascular and systemic physiology. Education: BSc in Human Genetics (University College London), DPhil in Molecular Medicine (University of Oxford) Her work bridges cell physiology and translational medicine, with key discoveries on hypoxia-inducible factors (HIFs), iron regulatory genes TMPRSS6 and GDF15 , and the role of hepcidin in altitude adaptation and chronic diseases. She utilizes tissue-specific animal models to study iron regulation in heart, kidney, placenta, and vasculature. Recent publications highlight her contributions to understanding: FLASH radiotherapy effects linked to iron-dependent lipid peroxidation Clinical implications of myocardial iron dynamics in heart failure Hepcidin's role in vascular protection and placental iron transfer Biomarker development for predictive iron deficiency diagnostics Scientific Leadership: British Heart Foundation Intermediate Fellowship (2012) MRC Senior Fellowship (2020) BioIron Society Board Member (2019) She collaborates with clinical teams on translational projects and serves as a Tutorial Fellow in Medicine at Brasenose College, mentoring students in physiological sciences.

• Fibrosis Research
• Liver Fibrosis
• Kidney Fibrosis
• +9 more

Karen Piper Hanley is Professor of Molecular Medicine and Head of Division in the Division of Diabetes, Endocrinology & Gastroenterology at the University of Manchester. She serves as the fibrosis lead in the Wellcome Trust Centre for Cell-Matrix Research and previously served as Director of Core Research Technologies (2019-2022). She is also an editorial board member for Scientific Reports. Her research focuses on fibrosis (scarring) mechanisms across multiple organs, particularly liver, kidney, and lung fibrosis. Her lab investigates the cellular and molecular basis of fibrotic disease, with emphasis on how pathological scar components are produced and how they signal to surrounding cells. Key areas include the role of SOX9 transcription factor, integrin beta-1 signaling, Group 1 PAKs, and YAP1 in fibrosis progression. Her recent publications reveal trends toward increased clinical translation of fibrosis research, with studies on health inequalities in liver cancer care, post-COVID diabetes incidence, and innovative approaches to liver disease detection. Her work increasingly integrates spatial transcriptomics and advanced omics technologies to understand cellular transitions in liver disease. Career-track postdoctoral fellowship from the University of Southampton (2006) As senior postgraduate tutor, she has mentored numerous PhD students who have presented at key conferences and authored high-quality manuscripts. All her PhD students have submitted and been awarded their degrees within 4 years. She has successfully guided previous Academic Clinical Fellows to win MRC clinical training fellowships. Her teaching extends to undergraduate Personal & Professional Development and supervision of MRes and BSc students, many of whom have achieved first-class degrees and prestigious awards. Her lab maintains active collaborations with Professor Neil Hanley's group on human development, stem cells, and regenerative medicine, bridging developmental biology with fibrosis research to understand why regeneration is impaired in chronic diseases.

• Anatomy
• Morphology
• Vascular Anatomy
• +4 more

Prof. Dr. Kenan Aycan is a Professor of Anatomy at Ahi Evran University's Faculty of Medicine, Department of Basic Medical Sciences, where he has served since 2019. He also holds the position of Department Head since 2020. Previously, he worked at Erciyes University as a School Director from 2011-2016. His academic career spans over four decades with significant contributions to anatomical sciences. Dr. Aycan earned his PhD in Basic Medical Sciences from Ege University's Faculty of Medicine (1983-1986) following his Bachelor's degree in Science from Ege University's Faculty of Science (1970-1975). He also holds a Certificate of Use of Experimental Animals from Erciyes University (2008). His research focuses on anatomical morphology, vascular structures, and developmental processes. Dr. Aycan has pioneered anatomical techniques including the 'Aycan's method' for corrosion preparations. His work spans comparative anatomy across various species, morphometric analyses of anatomical structures, and investigations into teratogenic effects and protective agents. He has extensively studied the foramen magnum using golden ratio principles, vascular anatomy of reproductive organs in ruminants, and auditory ossicles in sheep. Analysis of his recent publications (2021-2025) reveals consistent focus on anatomical methodology development, morphometric studies of key anatomical structures, vascular anatomy investigations, and research on developmental processes and teratology. His work often employs plastic injection and corrosion techniques, CT imaging, and comparative approaches across human and animal models. Dr. Aycan has mentored numerous graduate students, serving as primary advisor for over 20 Master's and PhD theses covering diverse anatomical topics from vascular variations to developmental studies. His collaborative network includes researchers like Tufan Ulcay, Burcu Kamaşak, and others across Turkish institutions.

• Clinical Toxicology
• Pharmacoepidemiology
• Poisoning
• +3 more

Professor Nicholas Buckley is a leading academic in Clinical Pharmacology at the University of Sydney and holds a Visiting Professor position at the University of Peradeniya, Sri Lanka. He serves as Research Director for the South Asian Clinical Toxicology Research Collaboration (SACTRC) and is a Consultant Clinical Pharmacologist & Toxicologist at the NSW Poisons Information Centre and Royal Prince Alfred Hospital. His work focuses on improving clinical toxicology practices, poison control policies, and understanding mechanisms of drug toxicity. Co-founder of SACTRC for agrochemical poisoning and snakebite research Chair of Australian Therapeutic Guidelines - Toxicology writing group Editorial roles in Clinical Toxicology, Drug Safety, and Australian Prescriber Research Interests include toxicovigilance, epidemiology of poisoning, acute kidney injury in poisoning/snakebite, pesticide safety interventions, antidote development, and pharmacoepidemiology of psychotropic drugs. His work combines clinical trials, population surveillance, and translational research. Scientific Contributions span 440+ peer-reviewed articles and 22 book chapters, with continuous funding since 2002. He has supervised over 20 higher degree students and leads international collaborations in low-and-middle-income countries through NIHR RIGHT4. Key Affiliations : Member of Charles Perkins Centre, Australian Medicines Handbook Editorial Advisory Board, and NIHR RIGHT4 programme.

Simon FraserView profile

Professor

• Healthcare
• Public Health
• Kidney Disease
• +3 more

Professor Simon Fraser is a public health physician and academic at the University of Southampton , specializing in kidney disease and multimorbidity. His work integrates epidemiology, health literacy, and inequality analysis to address chronic disease burdens. Educational Background: BM (University of Southampton, 1992) MSc in Public Health DM (Doctor of Medicine, 2014) Research Focus: Fraser's research spans kidney disease , multimorbidity , treatment burden , and health inequalities . Recent projects include the NURTuRE-CKD HRQoL Study and MELD-B , examining determinants of chronic disease progression and intervention design. Academic Contributions: His publications from 2024-2025 emphasize electronic health records for multimorbidity analysis, neonatal risk factors for adult comorbidity, and deprescribing strategies for older adults. Collaborations include NIHR Applied Research Collaboration Wessex and Kidney Research UK. Scientific Recognition: Fellow of the Faculty of Public Health (FFPH) Member of the Royal College of General Practitioners (MRCGP) Fellow of the Higher Education Academy (FHEA) Mentorship: Current PhD students include Emilia Mary Holland and Keegan Guan Ru Lee . He co-leads projects with leading researchers in public health and nephrology.

Canan DagdevirenView profile

Associate Professor

• Biomedical Engineering
• Piezoelectric Devices
• Wearable Electronics
• +6 more

Dr. Canan Dagdeviren is an Associate Professor and LG Career Development Professor of Media Arts and Sciences at the Massachusetts Institute of Technology, where she directs the Conformable Decoders research group at the MIT Media Lab. She joined the MIT faculty in January 2017 and has established herself as a leading innovator in conformable biomedical devices. Education: Ph.D. in Materials Science and Engineering, University of Illinois at Urbana-Champaign M.Sc. in Materials Science and Engineering, Sabanci University, Istanbul, Turkey B.Sc. in Physics Engineering, Hacettepe University, Ankara, Turkey Dr. Dagdeviren's research focuses on creating mechanically adaptive electromechanical systems that can intimately integrate with biological surfaces for sensing, actuation, and energy harvesting. She believes vital information from nature and the human body is 'coded' in various physical patterns, and her work develops 'conformable decoders' to translate these patterns into beneficial signals and energy. Her research spans wearable and implantable medical devices, with particular emphasis on piezoelectric systems that can be twisted, folded, stretched, wrapped, and implanted onto curvilinear surfaces of the human body without damage or significant alteration in performance. Analysis of her recent publications reveals a strong focus on medical applications of conformable electronics, particularly in ultrasound technology for breast cancer detection, deep brain stimulation, and bladder monitoring. Her work consistently bridges materials science, electrical engineering, and medical applications, with increasing emphasis on practical healthcare solutions that can be deployed outside clinical settings. Major Scientific Awards: NSF CAREER Award (2021) 3M Non-Tenured Faculty Award (2021) MIT Technology Review's Top 35 Innovators Under 35 (2015) Forbes' Top 30 Under 30 in Science (2015) National Academy of Engineering US Frontiers of Engineering Symposium participant (2019) Frank E. Perkins Award for Excellence in Graduate Advising Aziz Sancar Science Award Dr. Dagdeviren actively mentors graduate students and has received recognition for her advising excellence. Her research is supported by significant grants including the NSF CAREER award and has resulted in numerous patents and commercialization opportunities. She has developed innovative cleanroom-based courses at MIT that train students in microfabrication techniques for biomedical devices. The Conformable Decoders research group operates a specialized cleanroom facility at the MIT Media Lab, enabling the development and fabrication of novel conformable electronic systems. The group's work has attracted attention from major media outlets including BBC, CNN, and Nature, and has potential applications across multiple medical specialties including neurology, oncology, and urology.

Long CaiView profile

Professor

• Spatial Genomics
• Cellular Biology
• Developmental Biology
• +4 more

Long Cai is a Professor at the California Institute of Technology, affiliated with the Biology and Biological Engineering department. He pioneered the field of spatial genomics and co-developed transformative technologies such as seqFISH and MEMOIR. Research Interests: His work focuses on decoding biological systems through spatial genomics, integrating molecular imaging with computational analysis to uncover cellular organization in tissues. Key areas include developmental biology, neuroscience, kidney regeneration, and cancer biology. Publications: Recent studies highlight applications of spatial transcriptomics in kidney disease, brain nuclear architecture, and multi-omics tissue mapping. His research emphasizes creating high-resolution atlases of cellular dynamics. Scientific Awards: NIH Director’s Pioneer Award (2022) Labs & Collaborations: He leads the Cai Lab, which develops cutting-edge imaging tools in collaboration with the Elowitz Lab and other interdisciplinary teams.

KEMAL OZAN LÜLEView profile

Assistant Professor

• Internal Medicine
• Endocrinology
• Gastroenterology
• +6 more

KEMAL OZAN LÜLE is an Assistant Professor at Gaziantep University, Faculty of Medicine, Department of Internal Medicine , with an email contact at ozan@gantep.edu.tr . He holds an ORCID identifier and is registered in the YÖK Academic Information System. Education: Medical License from Dokuz Eylül University (2009–2016), Medical Specialization from Gaziantep University (2017–2021). Professional Experience: Specialist at Gaziantep Abdulkadir Yuksel State Hospital (2021–2024), General Practitioner at Arapgir Ali Özge State Hospital (2016–2017). Administrative Roles: Member of Measurement and Evaluation Board (2024), Internal Medicine Internship Education Coordinator (2024), English Medicine Assistant Coordinator (2024). His research focuses on Internal Medicine , with emphasis on Diabetes , Fatty Liver Disease , Neurocognitive Effects of diabetes treatments, Cancer Development linked to food preparation, Irritable Bowel Syndrome , and Adrenal Incidentaloma . Book Chapters: Development and Natural Course of Diabetic Fatty Liver Disease (2025), Effects of Pharmacological Agents on Neurological Functions (2023), Food Preparation Methods and Cancer (2023). He has co-authored multiple proceedings papers on topics including Temporal Arthritis , Lymphoma , Behçet’s Disease , and Fahr Syndrome , presented at national and international conferences.

• Cardiovascular Research
• Hypertension
• Pharmacology
• +5 more

Nancy J. Brown, M.D., is the Jean and David W. Wallace Dean of the Yale School of Medicine and holds the C.N.H. Long Professorship in Internal Medicine. Previously, she served as Chair of Vanderbilt Department of Medicine and Physician-in-Chief of Vanderbilt University Medical Center (2010–2020). Her academic career spans over three decades, with leadership roles in clinical care, research, and medical education. Education: MD, Harvard University (1986) AB in Molecular Biophysics and Biochemistry, Yale College (1981) Internship and Residency in Medicine, Vanderbilt University (1989) Fellowship in Clinical Pharmacology, Vanderbilt University (1991) Chief Resident, Vanderbilt University (1992) Research Interests: Dr. Brown’s work focuses on the renin-angiotensin-aldosterone system’s role in cardiovascular disease, hypertension, and thrombosis. Her lab has elucidated mechanisms linking aldosterone, bradykinin, and ACE inhibitors to inflammation, fibrosis, and cardiovascular risk. Current studies explore neprilysin inhibitors in heart failure and incretin-based therapies’ cardiovascular effects. Key Contributions: Identified genetic variants and African ancestry as risk factors for ACE inhibitor-associated angioedema Developed Vanderbilt’s Master of Science in Clinical Investigation program (2000) Advocated for physician-scientist development through leadership roles in NIH councils and professional organizations Recognition: Recipient of the Harriet Dustan Award, August M. Watanabe Prize, and Robert H. Williams Distinguished Chair of Medicine. Elected to the National Academy of Medicine and American Academy of Arts & Sciences. Labs/Teams: Leads the Yale School of Medicine’s cardiovascular research initiatives, focusing on translational studies of RAAS pathways and drug mechanisms.

Juris SalaksView profile

Associate Professor

• Medical Sciences
• History
• USSR Studies
• +4 more

Juris Salaks is an Acting Associate Professor and Director of the Institute of the History of Medicine and RSU Museum at Riga Stradiņš University. His work bridges medical history with archival research, focusing on pharmaceutical legacies and historical narratives in the Baltic region. Fields of Interest: Medical Sciences, History, USSR Studies, Central/Eastern Europe, and medical museology. Academic Leadership: Organized the 47th Congress of the International Society for the History of Medicine and co-led the "Bridging the Baltic IV" conference. Research Trends : Recent publications analyze the history of artificial kidney development and Roche's industrial archives, emphasizing cross-border scientific collaboration and preservation of medical heritage. His work aligns with SDGs for education and historical research. Scientific Awards : General Secretary (Other distinction, 2024) Pauls Stradiņš Award (Honorary award, 2001) Cross of Recognition (State award, 2023) Academic Contributions : As director of RSU Museum, he integrates medical history with interdisciplinary exhibitions, including projects on Fabergé's medical connections and Baltic medical innovators. Supervised 2 academic works and participated in 67 activities, including invited talks and editorial roles.

Golnoosh FarnadiView profile

Assistant Professor

• Algorithmic Fairness
• Privacy-preserving Machine Learning
• Responsible AI
• +5 more

Golnoosh Farnadi is an Assistant Professor at McGill University's School of Computer Science and an Adjunct Professor at the University of Montréal. She serves as a Visiting Faculty Researcher at Google, a Core Academic Member at MILA (Quebec Institute for Learning Algorithms), and holds a prestigious Canada CIFAR AI Chair. Farnadi co-directs McGill's Collaborative for AI & Society (McCAIS) and founded the EQUAL Lab (EQuity & EQuality Using AI and Learning algorithms), which focuses on advancing algorithmic fairness and responsible AI. Her educational background includes a Ph.D. in Computer Science from KU Leuven and Ghent University (2017), with postdoctoral research at the University of Montreal/MILA (2018-2020) and the University of California, Santa Cruz (2017-2018). During her doctoral studies, she was a visiting scholar at UCLA, University of Washington, Tsinghua University, and Microsoft Research. Dr. Farnadi's research centers on developing mathematical tools and algorithms for fairness-aware machine learning systems. Her work addresses bias and discrimination in AI decision-making across critical domains including healthcare, criminal justice, financial services, and social media. She has pioneered approaches to ensure fairness in deep learning models, particularly in sequential decision-making under uncertainty. Her research bridges theoretical foundations with practical applications, examining how AI systems can be designed to promote equity while maintaining performance. Analysis of her recent publications reveals a strong focus on practical implementations of fairness mechanisms across diverse AI applications. Her work spans technical domains from generative models and large language models to recommender systems and healthcare optimization. A unifying theme is the development of mathematically rigorous frameworks that balance performance with fairness considerations, with increasing attention to cultural diversity in multilingual AI systems and privacy-preserving fairness approaches. Google Scholar Award (2021) Facebook Research Award (2021) Rising Stars in AI Ethics (2021) Google Award for Inclusion Research (2023) WAI Responsible AI Leader of the Year Finalist (2023) 100 Brilliant Women in AI Ethics (2023) Canada CIFAR AI Chair Dr. Farnadi advises numerous doctoral and master's students across McGill University, University of Montréal, and MILA, with research focusing on fairness, privacy, and responsible AI. Her EQUAL Lab brings together researchers from computer science, social sciences, and policy domains to address systemic challenges in AI ethics. She has secured significant research funding from Google and other major organizations to support her work on fairness-aware AI systems, with applications spanning healthcare, social media safety, and public policy. The EQUAL Lab serves as a hub for interdisciplinary research on algorithmic fairness, bringing together computer scientists, social scientists, and policy experts. The lab's work spans theoretical foundations of fairness metrics, practical implementations in real-world systems, and policy recommendations for responsible AI deployment. Current projects include developing frameworks for fair kidney exchange programs, mitigating cultural stereotypes in multilingual language models, and creating privacy-preserving approaches for detecting online harms while protecting user data.

Jennifer LewisView profile

Professor

• Bioengineering
• Materials Science
• Soft Matter
• +7 more

Jennifer Lewis is the Hansjorg Wyss Professor of Biologically Inspired Engineering and Jianming Yu Professor of Arts and Sciences at Harvard University's Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS). Her research focuses on bioengineering, materials science, and advanced manufacturing, with emphasis on 3D-printed functional materials, organoids, and soft robotics. She leads the Lewis Research Group, which develops biomimetic technologies for regenerative medicine, energy systems, and robotics. Lewis holds appointments in SEAS, the Department of Chemistry and Chemical Biology, and the Wyss Institute for Biologically Inspired Engineering. Her research areas include applied mathematics, fluid mechanics, soft matter physics, and bioengineering applications such as kidney organoid models, vascularized tissues, and programmable materials. Notable innovations include kidney organoid-on-chip systems for drug testing, 3D-printed liquid crystal elastomers, and bioprinted cardiac tissues. Lewis was awarded the 2025 James Prize in Science and Technology Integration for pioneering interdisciplinary research. Her lab's projects span organ building blocks, immune-response modeling in transplanted tissues, and acoustophoretic printing techniques for high-resolution bioprinting. Collaborations include the NIH Somatic Cell Genome Editing Program and industry partnerships for bioprosthetic valve research. She advises on grants totaling over $20M and mentors a multidisciplinary team of postdocs and graduate students in materials science, biomedical engineering, and mechanical engineering. Lewis' lab facilities include the Pierce Hall lab (Cambridge) and Allston SEAS campus, with state-of-the-art 3D printing systems, microfluidics platforms, and bioreactors for organoid culture. Current projects aim to engineer functional human tissues for therapeutic applications and develop smart materials with programmable mechanical/chemical responses.

• Medical Genetics
• Nephrology
• Genomics
• +3 more

Dr. Ian Wilson is a researcher at Newcastle University with a focus on medical genetics, nephrology, and genomic analysis. His work spans genetic determinants of kidney diseases, mitochondrial disorders, and biomarker development. Notable contributions include studies on uromodulin genetics in African populations, copy-number variations in rare diseases, and kidney ciliopathies. He has collaborated extensively on projects involving genome sequencing, mitochondrial replacement therapy, and muscular dystrophy biomarkers. Wilson's research integrates computational tools like machine learning for predictive modeling in urolithiasis and employs advanced imaging techniques for disease progression monitoring. Key areas: Genetic epidemiology, renal genomics, mitochondrial DNA analysis Focus on translational applications: Biomarker development for kidney stones and muscular dystrophies Interdisciplinary collaborations in ophthalmology and orthopedics His publications reflect a commitment to advancing diagnostic accuracy and understanding complex genetic disorders through multi-omics approaches.